ADIPOCYTOKINES IN DEVELOPMENT INSULIN RESISTANCE IN OBESITY

Authors

  • Yarmysh N. V. Kharkiv National Medical University, Kharkiv, Ukraine
  • Kravchenko N. A. GI «L. T. Malaya Therapy National Institute of the NAMS of Ukraine», Kharkiv, Ukraine
  • Voitenko E. I. GI «L. T. Malaya Therapy National Institute of the NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2010.3.17

Keywords:

obesity, insulin resistance, adipose tissue

Abstract

Adipose tissue is key regulator of energy balance and plays an active role in the accumulation of lipids, as well as the synthesis and secretion of a wide range of adipokines that could potentially be involved in pathogenetic events associated with obesity

References

Grundy S. M. Obesity, metabolic syndrome, and cardiovascular disease [Text] / S. M. Grundy // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 2595– 2600.

Klaus S. Adipose tissue as a regulator of energy balance [Text] / S. Klaus // Curr Drug Targets. — 2004. — Vol. 5. — P. 241–250.

Trayhurn P. Adipokines: inflammation and the pleiotropic role of white adipose tissue [Text] / P. Trayhurn, I. S. Wood // Br. J. Nutr. — 2004. — Vol. 92. — P. 347–355.

Ahima R. S. Adipose tissue as an endocrine organ [Text] / R. S. Ahima, J. S. Flier // Trends Endocrinol. Metab. — 2000. — Vol. 11. — P. 327–332.

Hajer G. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases [Text] / G. Hajer, T.W. van Haeften, F. L. J. Visseren // European Heart Journal. — 2008. — Vol. 29. — P. 2959–2971.

Otto T. C. Adipose development: from stem cell to adipocyte [Text] / T. C. Otto, M. D. Lane // Crit. Rev. Biochem. Mol. Biol. — 2005. — Vol. 40. — P. 229–242.

Sharma A. M. Adipose tissue: a mediator of cardiovascular risk [Text] / A. M. Sharma // Int. J. Obes. Relat. Metab. Disord. — 2002. — Vol. 26 (Suppl 4). — P. S5–S7.

Adipose tissue as an endocrine organ: from theory to practice [Text] / M. H. Fonseca-Alaniz, J. Takada, M. I. Cardoso Alonso-Vale, F. B. Lima // J. Pediatr. (Rio J). — 2007. — Vol. 83 (5 Suppl.). — P. S192– 203.

Cinti S. The adipose organ: morphological perspectives of adipose tissues [Text] / S. Cinti // Proc. Nutr. Soc. — 2001. — Vol. 60. — P. 319–328.

Anghel S. I. Fat poetry: a kingdom for PPARγ [Text] / S. I. Anghel, W. Wahli // Research. — 2007. — Vol. 17. — P. 486–511.

Metabolism of lipids in human white Adipocyte [Text] / V. Large, O. Peroni, D. Letexier [et al.] // Diabetes Metab. — 2004. — Vol. 30. — P. 294– 309.

Unger R. H. Lipotoxicity of β-Cells in Obesity and in Other Causes of Fatty Acid Spillover [Text] / R. H. Unger, Yan-Ting Zhou //Diabetes. — 2001. — Vol. 50 (Suppl. 1). — P. S118–S121.

Kershaw E. E. Adipose tissue as an endocrine organ [Text] / E. E. Kershaw, J. S. Flier // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 2548– 2556.

Lazar M. A. The humoral side of insulin resistance [Text] / M. A. Lazar // Nat. Med. — 2006. — Vol. 12. — P. 43–44.

Relationship between adipocyte size and adipokine expression and secretion [Text] / T. Skurk, C. Alberti-Huber, C. Herder, H. Hauner // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92. — P. 1023– 1033.

Tsochatzis E. The evolving role of leptin and adiponectin in chronic liver diseases [Text] / E. Tsochatzis, G. V. Papatheodoridis, A. J. Archimandritis // Am. J. Gastroenterol. — 2006. — Vol. 101. — P. 2629–2640.

Trayhurn P. Adipocyte biology [Text] / P. Trayhurn // Obesity reviews. — 2007. — Vol. 8 (Suppl. 1). — P. 41–44.

Diamond F. The Endocrine Function of Adipose Tissue [Text] / F. Diamond // Growth, genetics and hormones. — 2002. — Vol. 18, issue 2. — P. 18–22.

Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation [Text] / C. E. Juge-Aubry, E. Somm, V. Giusti [et al.] // Diabetes. — 2003. — Vol. 52. — P. 1104–1110.

Relationship between serum adiponectin and leptin concentrations and body fat distribution [Text] / K. G. Park, K. S. Park, M. J. Kim [et al.] // Diabetes Res. Clin. Pract. — 2004. — Vol. 63. — P. 135– 142.

Redinger R. N. Obesity: pathophisiology and clinic features [Text] / R. N. Redinger //Gastroenterology and Hepatology. — 2007. — Vol. 3, Issue 1. — P. 856–863.

Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in nonobese and obese subjects [Text] / G. He, S. B. Pedersen, J. M. Bruun [et al.] // Horm Metab Res. — 2003. — Vol. 35. — P. 178–182.

Berg A. H. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [Text] / A. H. Berg // Nat.Med. — 2001. — Vol. 7. — P. 947–953.

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome [Text] / T. Kadowaki, T. Yamauchi, N. Kubota [et al.] // The Journal of Clinical Investigation. — 2006. — Vol. 116, Number 7. — P. 1784–1792.

Matrix Metalloproteinase Gene Delivery for Liver Fibrosis [Text] // Pharmaceutical Research. — 2007. — Vol. 25, No. 2. — P. 249–258.

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse [Text] / H. Yoshiji, S. Kuriyama, J. Yoshii [et al.] // Hepatology. — 2002. — Vol. 36. — P. 850–860.

Fat storage in adipocytes requires inactivation of leptin’s paracrine activity: implications for treatment of human obesity [Text] / M. Y. Wang, L. Orci, M. Ravazzola [et al.] // Proc. Natl. Acad. Sci.USA. — 2005. — Vol. 102. — P. 18011–18016.

Frübeck G. Intracellular signalling pathways activated by leptin [Text] / G. Frübeck // Biochem J. — 2006. — Vol. 393. — P. 7–20.

Unger R. H. Hyperleptinemia: protecting the heart from lipid overload [Text] / R. H. Unger // Hypertension. — 2005. — Vol. 45. — P. 1031–1034.

Schwartz M. W. Central nervous system control of food intake [Text] / M.W. Schwartz, S. C. Woods, D. Jr. Porte [et al.] // Nature. — 2000. — Vol. 404 (6778). — P. 661–671.

Kaminski T. Leptin and long form of leptin receptor genes expression in the hypothalamus and pituitary during the luteal phase and early pregnancy in pigs [Text] / T. Kaminski, N. Smolinska, A. Gajewska [et al.] // J. Physiol Pharmacol. — 2006. — Vol. 57. — P. 95–108.

The role of SOCS-3 in leptin signaling and leptin resistance [Text] / C. Bjorbaek, K. El-Hashimi, J. D. Frantz [et al.] // J. Biol. Chem. — 1999. — Vol. 274. — P. 30059–30065.

A central role for JNK in obesity and insulin resistance [Text] / J. Hiroshumi, G. Tuncman, L. Chang [et al.] // Nature. — 2002. — Vol. 420. — P. 333– 336.

Niswender K. D. Insulin and its evolving partne with leptin in the hypothalami of energy homeostatis [Text] / K. D. Niswender, D. G. Baskin, M.W. Schwartz // TRENDS in Endocrinology and Metabolism. — 2004. — Vol. 15, No. 8. — P. 341–348.

Sethi J. K. The role of TNF alpha in adipocyte metabolism [Text] / J. K. Sethi, G. S. Hotamisligil // Semin. Cell Dev. Biol. — 1999. — Vol. 10. —P. 19–29.

Adipokines and insulin resistance [Text] / K. Rabe, V. Lehrke, K. G. Parhofer [et al.] // Mol. Med. —2008. — Vol. 14 (11–12). — P. 741–751.

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? [Text] / S. Engeli, P. Schling, K. Gorzelniak [et al.] // Int. J. Biochem. Cell Biol. — 2003. — Vol. 35. — P. 807–825.

Weight loss and the renin-angiotensin-aldosterone system [Text] / S. Engeli, J. Bohnke, K. Gorzelniak [et al.] // Hypertension. — 2005. — Vol. 45. — P. 356–362.

Sorhede W. M. The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice [Text] / W. M. Sorhede, C. Magnusson, B. Ahren // Regul. Pept. — 2005. — Vol. 131. — P. 12–17.

Luk T. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity [Text] / T. Luk, Z. Malam, J. C. Marshall // Journal of Leukocyte Biology. — 2008. —Vol. 83. — P. 804–816.

The hormone resistin links obesity to diabetes [Text] / C. M. Steppan, S. T. Bailey, S. Bhat [et al.] // Nature. — 2001. — Vol. 409. — P. 307–312.

Increased resistin gene and protein expression in human abdominal adipose tissue [Text] / P. G. McTernan, C. L. McTernan, R. Chetty [et al.] // J. Clin. Endocrinol. Metab. — 2002. — Vol. 87. — P. 2407–2410.

Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation [Text] / A. Yao-Borengasser, N. Rasouli, V. Varma [et al.] // Diabetes. — 2006. —Vol. 55(10). — P. 2811–2818.

Moldes M. Adiponutrin gene is regulated by insulin and glucose in human adipose tissue [Text] / M. Moldes, G. Beauregard, M. Faraj // European Journal of Endocrinology. — 2006. — Vol. 155, Issue 3. — P. 461–468.

Holst D. New factors in the regulation of adipose differentiation and metabolism [Text] / D. Holst, P. A. Grimaldi // Curr. Opin. Lipidol. — 2002. — Vol. 13. — P. 241–245.

Skurk T. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1 [Text] / T. Skurk, H. Hauner // Int. J. Obes. Relat. Metab. Disord. — 2004. — Vol. 28. — P. 1357–1364.

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk [Text] / I. Juhan-Vague, M. C. Alessi, A. Mavri [et al.] // J. Thromb. Haemost. — 2003. — Vol. 1. — P. 1575–1579.

Obesity is associated with macrophage accumulation in adipose tissue [Text] / S. P. Weisberg, D. McCann, M. Desai [et al.] // J. Clin. Invest. — 2003. — Vol. 112. — P. 1796–1808.

Recent advances in the relationship between obesity, inflammation, and insulin resistance [Text] / J. P. Bastard, M. Maachi, C. Lagathu [et al.] // Eur. Cytokine Netw. — 2006. — Vol. 17 (1). — P. 4–12.

Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone [Text] / G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli

[et al.] // Diabetes. — 2005. — Vol. 5. — P. 2305– 2310.

Gordon S. Monocyte and macrophage heterogeneity [Text] / S. Gordon, P. R. Taylor // Nat. Rev. Immunol. — 2005. — Vol. 5. — P.953–964.

Suganami T., Tanimoto-Koyama K., Nishida J. et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages [Text] // Arterioscler. Thromb. Vasc. Biol. — 2007. — Vol. 27. — P. 84–91.

Permana P. A., Menge C., Reaven P. D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance [Text] // Biochem. Biophys. Res. Commun. — 2006. — Vol. 341. — P. 507– 514.

Zhao T., Hou M., Xia M. et al. Globular adiponectin decreases leptin-induced tumor necrosis factor-α expression by murine macrophages: involvement of cAMP-PKA and MAPK pathways [Text] // Cell Immunol. — 2006. — Vol. 238. — P. 19–30.

Tilg H., Hotamisligil G. S. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance [Text] // Gastroenterology. — 2006. — Vol. 131. — P. 934–945.

Emanuelli B., Glondu M., Filloux C. et al. The potential role of SOCS-3 in the interleukin-1β-induced desensitization of insulin signaling in pancreatic β-cells [Text] // Diabetes. — 2004. — Vol. 53 (Suppl. 3). — P. S97–S103.

Hotamisligil G. S., Peraldi P., Budavari A. et al. IRSv1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha andobesityinduced insulin resistance [Text] // Science. — 1996. — Vol. 271. — P. 665–678.

Braissant O.., Foufelle F., Scotto C. et al. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, - β, and -γ in the adult rat [Text] // Endocrinology. — 1996. — 137, № 1. — P. 354–366.

Vidal-Puig A., Jimenez-Linan M., Lowell B. B. et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents [Text] // J. Clin. Invest. — 1996. — Vol. 97. — P. 2553–2561.

Imai T., Takakuwwa R., Marchand S., et al. PPARγ is required in mature white and brown adipocytes for their survival in the mouse [Text] // Proceeding of the National Academy of Sciences of the United States of America. — 2004. — 101. — P. 4543–4547.

Kubota N., Terauchi Y., Miki H. et al. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance [Text] // Molecular Cell. — 1999. — Vol. 4, № 4. — P. 597–609.

Odegaard J. I. Macrophagespecific PPARγ controls alternative activation and improves insulin resistance [Text] / J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth [et al.] // Nature. — 2007. — Vol. 447, № 7148. — P. 1116–1120.

Hausman G. J. Search for the preadipocyte progenitor cell [Text] / G. J. Hausman, D. B. Hausman // J. Clin. Invest. — 2006. — Vol. 116. — P. 3103– 3106.

Maeda N. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adiposederived protein [Text] / N. Maeda, M. Takahashi, T. Funahashi [et al.] // Diabetes. — 2001. — Vol. 50. — P. 2094–2099.

Nawrocki A. R. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists [Text] / A. R. Nawrocki, M.W. Rajala [et al.] // J. Biol. Chem. — 2006. — Vol. 281. —

P. 2654–2660.

Yu J. G. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects [Text] / J. G. Yu., S. Javorschi, A. L. Hevener. [et al.] // Diabetes. — 2002. — Vol. 51. — P. 2968–2974.

Burgermeister E. A novel partial agonist of peroxisome proliferator-activated receptor-γ (PPARγ) recruits PPARγ-coactivator-1α, prevents triglyceride accumulation, and potentiates insulin signaling in vitro [Text] / E. Burgermeister, A. Schnoebelen, A. Flament [et al.] // Molecular Endocrinology. — 2006. — Vol. 20, No. 4. — P. 809–830.

Fang Zhang. Selective Modulators of PPAR-γ Activity: Molecular Aspects Related to Obesity and Side-Effects [Text] / Fang Zhang, B. E. Lavan, M. Francine // PPAR Research. — 2007. — Vol. 2007. — Article ID 32696. — 7 p.

Downloads

Published

2010-10-12

How to Cite

Yarmysh, N. V., Kravchenko, N. A., & Voitenko, E. I. (2010). ADIPOCYTOKINES IN DEVELOPMENT INSULIN RESISTANCE IN OBESITY. Problems of Endocrine Pathology, 33(3), 110-121. https://doi.org/10.21856/j-PEP.2010.3.17

Similar Articles

You may also start an advanced similarity search for this article.